Statistics for ADC Therapeutics SA (id:10100 ADCT)

Valuation metrics

Market cap

288.14M

Enterprise value

456.20M

Trailing P/E (ttm)

-0.68

Forward P/E

-1.97

PEG ratio

-1.97

Price/Sales (ttm)

4.07

Price/Book (mrq)

-1.45

Enterprise Value/Revenue

6.45

Enterprise Value/EBITDA

-3.33

Overview

Shares outstanding

96.69M

Float

77.09M

Shares short

3.51M

% Held by insiders

0.21%

% Held by institutions

0.59%

Average volume (10 days)

416.52K

Average volume (90 days)

Price summary

52-Week low

0.69

52-Week high

6.04

52-Week change

63.62%

Beta

1.60

50-Day moving average

3.02

200-Day moving average

3.66

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-300.00%

Operating margin

-192.61%

Operational effectiveness

Return on assets

-21.17%

Return on equity

161.93%

Income statement

Revenue (ttm)

0.77

Revenue per share (ttm)

0.77

Quarterly revenue growth (yoy)

Gross profit (ttm)

67.03M

EBITDA

-136,868,000.00

Net income to common (ttm)

-212,150,000.00

Diluted EPS (ttm)

-2.50

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

274.27M

Total cash per share (mrq)

2.84

Total debt (mrq)

447.18M

Total Debt/Equity (mrq)

-3.40

Current ratio (mrq)

492.00%

Book value per share (mrq)

-1.78

Cash flow

Cash flow statement

-133,616,000.00

Levered free cash flow (LFCF)

-89,609,128.00